MX2021006314A - Sustancia para el tratamiento y/o prevención de enfermedades de intolerancia, y método de diseño y método de preparación de la misma. - Google Patents

Sustancia para el tratamiento y/o prevención de enfermedades de intolerancia, y método de diseño y método de preparación de la misma.

Info

Publication number
MX2021006314A
MX2021006314A MX2021006314A MX2021006314A MX2021006314A MX 2021006314 A MX2021006314 A MX 2021006314A MX 2021006314 A MX2021006314 A MX 2021006314A MX 2021006314 A MX2021006314 A MX 2021006314A MX 2021006314 A MX2021006314 A MX 2021006314A
Authority
MX
Mexico
Prior art keywords
substance
treating
preparation
intolerance diseases
design method
Prior art date
Application number
MX2021006314A
Other languages
English (en)
Inventor
futian Dong
Original Assignee
Futian Dong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Futian Dong filed Critical Futian Dong
Priority claimed from PCT/CN2019/120724 external-priority patent/WO2020108445A2/zh
Publication of MX2021006314A publication Critical patent/MX2021006314A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Physiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)

Abstract

La presente invención describe una sustancia para tratar y/o prevenir enfermedades de intolerancia y un método de diseño y método de preparación de la misma. La estructura estable correspondiente a la sustancia relacionada con la enfermedad de intolerancia se utiliza como sustancia para tratar y/o prevenir la enfermedad de intolerancia. La esencia de la enfermedad es el desequilibrio del sistema de estructura biológica. El desequilibrio de la estructura de la sustancia en el sistema de estructura biológica provocará enfermedades relacionadas con dicha sustancia. La presente invención se refiere al tratamiento y/o prevención de la enfermedad de intolerancia mediante el reconocimiento de la estructura estable correspondiente a la sustancia por parte del organismo, ajustando la expresión de su expresión génica o genes mediante la autoadaptación, autoorganización y otras funciones del sistema estructural del cuerpo y restaurar el equilibrio de la estructura de la sustancia en el sistema de estructura biológica.
MX2021006314A 2018-11-28 2019-11-25 Sustancia para el tratamiento y/o prevención de enfermedades de intolerancia, y método de diseño y método de preparación de la misma. MX2021006314A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201811437559 2018-11-28
CN201910787180.5A CN111228497A (zh) 2018-11-28 2019-08-25 一种治疗和/或预防不耐受疾病的物质及其设计方法和制备方法
PCT/CN2019/120724 WO2020108445A2 (zh) 2018-11-28 2019-11-25 一种治疗和/或预防不耐受疾病的物质及其设计方法和制备方法

Publications (1)

Publication Number Publication Date
MX2021006314A true MX2021006314A (es) 2021-08-11

Family

ID=70863212

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2021006314A MX2021006314A (es) 2018-11-28 2019-11-25 Sustancia para el tratamiento y/o prevención de enfermedades de intolerancia, y método de diseño y método de preparación de la misma.
MX2021006313A MX2021006313A (es) 2018-11-28 2019-11-25 Sustancia para el tratamiento y/o prevencion de enfermedades alergicas, y metodo de dise?o y metodo de preparacion de la misma.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021006313A MX2021006313A (es) 2018-11-28 2019-11-25 Sustancia para el tratamiento y/o prevencion de enfermedades alergicas, y metodo de dise?o y metodo de preparacion de la misma.

Country Status (9)

Country Link
US (3) US20220072061A1 (es)
EP (3) EP3928781A4 (es)
JP (3) JP2022511783A (es)
KR (3) KR20210095668A (es)
CN (39) CN111228498A (es)
AU (5) AU2019388795A1 (es)
CA (3) CA3121285A1 (es)
MX (2) MX2021006314A (es)
SG (1) SG11202105593QA (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440448B1 (en) * 1998-03-16 2002-08-27 Joseph Intelisano Food supplement/herbal composition for health enhancement
US6773695B2 (en) * 2000-10-05 2004-08-10 Mannkind Corporation Modulation of allergic response
AU2003258232A1 (en) * 2002-08-20 2004-03-11 Primezyme, Inc. Food supplements from freeze-dried bovine tissues and method of ordering food supplements
KR100733982B1 (ko) * 2004-07-19 2007-06-29 이도중 암 치료 및 예방, 항균 및 항산화 효과를 갖는 목초액 유기물
CN107432915A (zh) * 2016-05-25 2017-12-05 卢祥平 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、肺炎、胃肠炎的药物
KR20190106998A (ko) * 2016-11-21 2019-09-18 비포어 브랜즈, 인크. 액체 알러젠 조성물 및 이의 제조 방법

Also Published As

Publication number Publication date
CN111821456A (zh) 2020-10-27
CN111228494A (zh) 2020-06-05
CN111228497A (zh) 2020-06-05
CN111228496A (zh) 2020-06-05
EP3928781A2 (en) 2021-12-29
EP3888665A4 (en) 2022-11-16
EP3928781A4 (en) 2022-11-16
CN111821445A (zh) 2020-10-27
CA3124550A1 (en) 2020-06-04
CN111803638A (zh) 2020-10-23
CN111821452A (zh) 2020-10-27
CN111821455A (zh) 2020-10-27
CN111920952A (zh) 2020-11-13
CN111228493A (zh) 2020-06-05
JP2022513656A (ja) 2022-02-09
CN111803637A (zh) 2020-10-23
CN111821440A (zh) 2020-10-27
CN111803642A (zh) 2020-10-23
MX2021006313A (es) 2021-08-11
US20220118084A1 (en) 2022-04-21
KR20210110305A (ko) 2021-09-07
CN111821453A (zh) 2020-10-27
CA3121285A1 (en) 2020-06-04
CN111803640A (zh) 2020-10-23
CN111701022A (zh) 2020-09-25
CN111228499A (zh) 2020-06-05
CN111228498A (zh) 2020-06-05
AU2023203105A1 (en) 2023-07-13
JP2022522574A (ja) 2022-04-20
CN111821446A (zh) 2020-10-27
SG11202105593QA (en) 2021-06-29
CA3121295A1 (en) 2020-06-04
JP2022511783A (ja) 2022-02-01
US20220072061A1 (en) 2022-03-10
AU2019386000A1 (en) 2021-07-01
AU2019388795A1 (en) 2021-06-24
CN111821450A (zh) 2020-10-27
CN111821437A (zh) 2020-10-27
KR20210110809A (ko) 2021-09-09
EP3888680A2 (en) 2021-10-06
CN111821448A (zh) 2020-10-27
CN111821447A (zh) 2020-10-27
CN111803643A (zh) 2020-10-23
CN111228492A (zh) 2020-06-05
AU2019386779A1 (en) 2021-06-24
US20220143176A1 (en) 2022-05-12
CN111821441A (zh) 2020-10-27
KR20210095668A (ko) 2021-08-02
CN111821443A (zh) 2020-10-27
CN111228495A (zh) 2020-06-05
CN111803641A (zh) 2020-10-23
CN111803639A (zh) 2020-10-23
CN111821457A (zh) 2020-10-27
EP3888680A4 (en) 2022-11-16
CN111821454A (zh) 2020-10-27
CN111821442A (zh) 2020-10-27
CN111803644A (zh) 2020-10-23
AU2023203218A1 (en) 2023-06-15
CN111821444A (zh) 2020-10-27
CN111821439A (zh) 2020-10-27
EP3888665A2 (en) 2021-10-06
CN111821438A (zh) 2020-10-27
CN111821449A (zh) 2020-10-27
CN111821451A (zh) 2020-10-27

Similar Documents

Publication Publication Date Title
PH12020551923A1 (en) Methods and compositions for treating cancer
MX2020012797A (es) Anticuerpos biespecificos anti-pvrig/anti-tigit y métodos de uso.
SG10201805246XA (en) Approximated parameter adaptation
PH12020500371A1 (en) Spirocycle compounds and methods of making and using same
MX2018010971A (es) Compuestos y métodos para modular la tirosina cinasa de bruton.
MX2021002100A (es) Sistemas y metodos para dimensionar e implantar valvulas cardiacas protesicas.
MY196448A (en) Anti-Htra1 Antibodies and Methods of use Thereof
MX2022007801A (es) Formas polimorficas de rad1901-2hcl.
CR20200089A (es) Compuestos espirocíclicos y sus métodos de preparación y uso
MX2019015676A (es) Uso de isovaleril espiramicina i, ii y/o iii en la fabricación de medicamentos para el tratamiento y/o la prevención de tumores, y el medicamento.
PH12021550413A1 (en) Vitamin d pediatric dosage forms, methods of making and using
WO2020033019A3 (en) Novel mct4 inhibitors and uses thereof
MX2020013713A (es) Formas polimorficas de rad1901-2hcl.
PH12018502318A1 (en) Compositions and methods for treatment of inflammation of infection of the eye
JOP20190164A1 (ar) تركيبات وطرق لعلاج داء فاربر
MX2020012990A (es) Formulaciones de tegavivint y compuestos relacionados.
WO2020047144A3 (en) Ophthalmic formulations, process for preparing the same and method for administering the same
WO2018211324A8 (en) Prodrugs for the treatment of disease
PH12021550121A1 (en) Methods of treating hfpef employing dapagliflozin and compositions comprising the same
WO2017161344A8 (en) Compositions and methods for treating parasitic diseases
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
MX2019010060A (es) Composiciones y metodo para tratar cancer.
MX2021006314A (es) Sustancia para el tratamiento y/o prevención de enfermedades de intolerancia, y método de diseño y método de preparación de la misma.
SA522431538B1 (ar) طُرق وتركيبات لعلاج تساقط الشعر
MX2021011699A (es) Derivados de quinolina y su uso para el tratamiento del cancer.